Introduction Oesophagectomy is a complex oncological procedure usually undertaken in high-volume metropolitan centres, with limited published outcome data from regional New Zealand centres. Aims To evaluate oncological outcomes following oesophagectomy at Palmerston North Hospital and compare these with benchmarks from the UK National Oesophago-Gastric Cancer Audit (NOGCA). Methods A retrospective cohort study was conducted of consecutive patients undergoing oesophagectomy for oesophageal malignancy at Palmerston North Hospital between 2014 and 2025. Clinicopathological variables included pathological tumour stage, nodal status, nodal burden, lymph node yield, and margin status. Outcomes included recurrence, survival, readmission, early postoperative mortality, and were compared descriptively with contemporary NOGCA audit data. Results 99 patients underwent oesophagectomy. The cohort predominantly comprised locally advanced disease, with 47 patients (47.5%) demonstrating no pathological lymph node involvement. The mean lymph node yield was 22.7 ± 9.9, with 21 patients (21.2%) having fewer than 15 lymph nodes examined. Increasing nodal burden was associated with reduced survival. R0 resection was achieved in 88 patients (88.9%). Disease recurrence occurred in 38 of 78 patients (48.7%). Among patients with available follow-up, 1-year survival was 79.3% (69 of 87) and 5-year survival was 47.2% (34 of 72). Early postoperative mortality occurred in 4 patients (4.0%) at both 30 and 90 days. Readmission occurred in 16 of 94 patients (17.0%) within 30 days and 8 of 93 patients (8.6%) within 90 days. Conclusion Pathological nodal burden was a key determinant of outcome following oesophagectomy in this cohort. Oncological quality and early postoperative outcomes were comparable with UK national benchmarks, despite this cohort spanning an earlier treatment era. These findings support the safe delivery of complex oesophageal cancer surgery in well-resourced regional centers.